Related Experiment Video
Updated: Aug 23, 2026
In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
Active inhibition of plasma cell development in resting B cells by microphthalmia-associated transcription factor
Ling Lin1, Andrea J Gerth, Stanford L Peng
1Department of Internal Medicine/Rheumatology, Washington University School of Medicine, Campus Box 8045, CSRB 6617, 660 S. Euclid Ave., St. Louis, MO 63110, USA.
Abstract:
B cell terminal differentiation involves development into an antibody-secreting plasma cell, reflecting the concerted activation of proplasma cell transcriptional regulators, such as Blimp-1, IRF-4, and Xbp-1. Here, we show that the microphthalmia-associated transcription factor (Mitf) is highly expressed in naive B cells, where it antagonizes the process of terminal differentiation through the repression of IRF-4. Defective Mitf activity results in spontaneous B cell activation, antibody secretion, and autoantibody production. Conversely, ectopic Mitf expression suppresses the expression of IRF-4, the plasma cell marker CD138, and antibody secretion. Thus, Mitf regulates B cell homeostasis by suppressing the antibody-secreting fate.
Insights
Microphthalmia-associated transcription factor (Mitf) suppresses B cell terminal differentiation by repressing IRF-4. Loss of Mitf activity leads to spontaneous autoantibody production, highlighting Mitf
Area of Science:
- Immunology
- Molecular Biology
- Transcription Factor Regulation
Background:
- B cell terminal differentiation is a critical process for adaptive immunity, leading to antibody-secreting plasma cells.
- This differentiation is orchestrated by key transcriptional regulators including Blimp-1, IRF-4, and Xbp-1.
- The role of microphthalmia-associated transcription factor (Mitf) in naive B cells and its impact on terminal differentiation remain incompletely understood.
Purpose of the Study:
- To investigate the function of microphthalmia-associated transcription factor (Mitf) in naive B cells.
- To determine the role of Mitf in regulating B cell terminal differentiation and antibody production.
- To elucidate the molecular mechanisms by which Mitf controls the plasma cell fate.
Main Methods:
- Analysis of Mitf expression in naive B cells.
- Investigating the effect of Mitf activity on the expression of IRF-4 and CD138.
- Assessing antibody secretion and autoantibody production in response to altered Mitf levels.
- Utilizing techniques to manipulate Mitf expression, including ectopic expression and assessing defective activity.
Main Results:
- Microphthalmia-associated transcription factor (Mitf) is highly expressed in naive B cells.
- Mitf antagonizes B cell terminal differentiation by repressing the expression of IRF-4.
- Defective Mitf activity results in spontaneous B cell activation, antibody secretion, and autoantibody production.
- Ectopic Mitf expression suppresses IRF-4, CD138, and antibody secretion, confirming its inhibitory role.
Conclusions:
- Mitf acts as a crucial suppressor of B cell terminal differentiation.
- Mitf maintains B cell homeostasis by preventing premature or inappropriate activation of the antibody-secreting plasma cell fate.
- Targeting Mitf could offer new strategies for modulating autoimmune responses.
